InflaRx Announces Positive Topline Results from the Single Ascending Dose (SAD) Phase I Study with C5aR Inhibitor INF904

1 year ago

Moderna and Immatics Announce Strategic Multi-Platform Collaboration to Develop Innovative Oncology Therapeutics

1 year ago

XORTX Announces Participation at Upcoming Investor Conferences

1 year ago

Eagle Pharmaceuticals to Present CAL02 Trial in Progress at the 2023 ASM/ESCMID Joint Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance

1 year ago

New Data From an Influenza Challenge Study Further Support the Prophylactic Potential of INNA-051 to Accelerate Viral Clearance

1 year ago

SpringWorks Therapeutics Appoints Dr. Tai-An Lin as Chief Scientific Officer

1 year ago

Oculis Expands its Executive Leadership Team and Appoints Rebecca Weil, Ph.D. as Chief Commercial Officer as it Enters Pre-Commercial Phase

1 year ago

Justera Health Launches Health and Wellness Retail Stores

1 year ago

Toronto, Ontario--(Newsfile Corp. - September 11, 2023) - Justera Health Ltd. (CSE: VTAL) (OTC Pink: SCRSF) (formerly ScreenPro Security Inc.) ("Justera" or the…

Save the date: IRLAB holds Capital Markets Day on October 17, 2023

1 year ago

GOTHENBURG, SE / ACCESSWIRE / September 11, 2023 / IRLAB Therapeutics (STO:IRLAB-A) (FRA:6IRA) Gothenburg, Sweden, September 11, 2023 - IRLAB…

Aesthetic Medical International Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency

1 year ago

SHENZHEN, China, Sept. 08, 2023 (GLOBE NEWSWIRE) -- Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) (the “Company” or “AIH”),…

Show more Posts
Show previous Posts